查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433399

2023-2030 年全球医疗保健市场 EConsent

Global EConsent in Healthcare Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030 年），全球医疗保健市场的CAGR将达到 9.9%。市场的成长归因于赞助商控制力的增强。 eConsent 解决方案中新增的分层授权选项和额外功能为赞助商提供了更多控制和自订功能。这满足了根据研究需求量身定制同意解决方案的愿望。例如，2021年4月，Signant Health凭藉最新发布的Smart Signals eConsent，拓展了电子知情同意产品并增强了自身能力。关键产品功能增强和分层许可选项为申办者提供了对任何研究设计获得电子知情同意和重新同意的额外控制。

细分市场前景

全球医疗保健市场共识按註册类型、部署模式和表单类型细分。根据註册类型，市场分为现场同意和远端同意。根据部署模式，市场分为基于云端的和基于网路的。此外，根据形式类型，市场细分为普遍同意、普遍同意但特定拒绝、普遍拒绝特定同意、普遍拒绝。基于云端的子类别预计将占据部署模式细分市场的很大一部分市场份额。这一增长可归因于越来越多地使用基于云端的解决方案，因为它具有最大限度地减少管理负担并保持站点和研究团队合规性的好处。此外，基于云端的电子同意透过结合创新技术和多媒体来改进流程，为潜在的试验参与者提供互动式知情同意体验。

预计现场细分市场将在全球医疗保健市场 EConsent 中占据相当大的份额

在这些应用中，内容管理系统（CMS）细分市场预计将在全球医疗保健市场中占据相当大的份额。细分市场的成长归因于不同人群的参与。现场电子同意可以服务于各种人群，包括具有不同程度的数位素养或技术访问受限的人群，从而能够公平地获取试验材料。例如，2021 年 7 月，CASTOR 推出了可扩展的病患登记和 eConsent 平台。临床试验受益于权力下放，因为它使更广泛的个人更容易获得临床试验。该过程还鼓励透明度和效率，透过在整个研究招募和入组过程中提供无缝过渡来减轻患者的负担。

区域展望

全球医疗保健市场按地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，欧洲预计将在全球市场中占据显着份额，因为该地区的医疗保健系统发达，此外还非常重视资料保护和患者权利，这使得 eConsent 解决方案成为一个有吸引力的选择。日益增多的医疗保健数位化倡议，例如电子健康记录和互通性标准的广泛采用，为电子同意的部署提供了有利的环境。

北美地区预计在全球医疗保健市场 EConsent 中将以显着的CAGR成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。区域成长归因于比较理解研究。比较患者对电子同意书与纸本知情同意书 (ICF) 的理解程度的比较研究已经产生了积极的结果。这些研究强调电子同意的改进或可比较知识有助于其被接受。根据美国国立卫生研究院 (gov.) 2023 年 9 月的数据，本次审查总共纳入了 36 项符合资格标准的研究，以及手动检索的额外结果出版物。这些出版品总共描述了 35 项研究，其中 2 项研究各由 2 篇出版品涵盖。大多数研究（28/35，80%）在北美进行，其中美国占 26 项研究，加拿大占 2 项研究。

此外，在对涉及总共 8,778 名参与者的 26 项研究进行的综合分析中，评估了与电子同意相关的患者理解程度。在这些研究中，有 20 项专门比较了电子同意和纸本知情同意书 (ICF) 的理解程度，共有 6,769 名参与者提供了比较资料。研究结果表明，与纸本 ICF 相比，电子同意要么表现出显着更好的理解，要么在没有统计意义的情况下更好地理解，要么总体理解没有显着差异。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Citadel Group Ltd.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Florence Healthcare, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Health Catalyst
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按註册类型分類的全球医疗保健市场 EConsent
    • 现场
    • 远端同意
  • 按部署模式分類的全球医疗保健市场 EConsent
    • 基于云端的
    • 基于网路
  • 按表格类型分類的全球医疗保健市场 EConsent
    • 普遍同意
    • 普遍同意但具体拒绝
    • 经特别同意的一般拒绝
    • 普遍否认

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • 5thPort, LLC
  • Calysta EMR
  • Cloudbyz
  • Concentric
  • EvidentIQ Group GmbH
  • IQVIA
  • Magentus Group Pty Ltd.
  • Medable, Inc.
  • Medrio, Inc.
  • ObvioHealth
  • Signant Health
  • Sitero
  • Suvoda LLC,
  • Thieme Compliance GmbH
  • Veeva Systems
Product Code: OMR2027988

Global EConsent in Healthcare Market Size, Share & Trends Analysis Report by Enrollment Type (On-site, and Remote Consent), by Deployment Mode (Cloud-based, and Web-based) and by Form Type (General Consent, General Consent with Specific Denial(s), General Denial with Specific Consent(s), and General Denial), Forecast Period (2023-2030)

The global econsent in healthcare market is anticipated to grow at a CAGR of 9.9% during the forecast period (2023-2030). The market's growth is attributed to the increased sponsor control. The addition of tiered license options and extra features in eConsent solutions offers sponsors more control and customization capabilities. This satisfies the desire for customized consent solutions based on the needs of the study. For instance, in April 2021, Signant Health, with the latest released of Smart Signals eConsent, the company has expanded its electronic informed consent products and strengthened its capabilities. Key product functionality enhancements and tiered license options offer sponsors additional control over getting electronic informed consent and reconsent for any study design.

Segmental Outlook

The global econsent in healthcare market is segmented on the enrollment type, deployment mode, and form type. Based on the enrollment type, the market is sub-segmented on-site, and remote consent. Based on the deployment mode, the market is sub-segmented into cloud-based, and web-based. Furthermore, on the basis of form type, the market is sub-segmented into general consent, general consent with specific denial(s), general denial with specific consent(s), general denial. The cloud-based subcategory is expected to capture a significant portion of the market share within the deployment mode segment. The growth can be attributed to the growing use of cloud-based solutions owing to the benefits of minimizing administrative burden and maintaining compliance for sites and study teams. Furthermore, cloud-based eConsent improves the process by incorporating innovative technology and multimedia to provide potential trial participants with an interactive informed consent experience.

The On-Site Sub-Segment is Anticipated to Hold a Considerable Share of the global EConsent in Healthcare Market

Among the application, the content management systems (CMS) sub-segment is expected to hold a considerable share of the global econsent in healthcare market. The segmental growth is attributed to the diverse populations engagement. On-site eConsent can serve a variety of demographics, including those with various degrees of digital literacy or restricted access to technology, enabling fair access to trial material. For instance, in July 2021,CASTOR Launched Scalable Patient Enrollment and eConsent Platform. Clinical trials benefit from decentralization as it makes them more accessible to a wider range of individual. The process additionally encourages transparency and efficiency, reducing the burden on patients by providing a seamless transition throughout the study recruitment and enrollment process.

Regional Outlook

The global econsent in healthcare market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the region's healthcare system is well-developed, in addition to is a significant emphasis on data protection and patient rights, making eConsent solutions an appealing option. The increasing healthcare digitization initiatives, such as widespread adoption of electronic health records and interoperability standards, present a conducive climate for eConsent deployment.

The North America Region is Expected to Grow at a Significant CAGR in the global EConsent in Healthcare Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the comparative comprehension studies. Comparative research comparing patient comprehension of eConsenting opposed to paper-based Informed Consent Forms (ICFs) has produced positive results. These studies emphasizing improved or comparable knowledge of eConsenting assist to its acceptance. According to the National Institute of Health (gov.) in September 2023, a total of 36 studies meeting the eligibility criteria were included in this review, along with an additional outcomes publication that was retrieved manually. These publications described a total of 35 studies, with 2 studies covered by 2 publications each. The majority of the studies (28/35, 80%) were conducted in North America, with the US accounting for 26 studies and Canada for 2 studies.

Furthermore, in a comprehensive analysis of 26 studies involving a total of 8,778 participants, the aspects of patient comprehension were evaluated in relation to eConsenting. Out of these studies, 20 specifically compared comprehension between eConsenting and paper-based informed consent forms (ICFs), with a total of 6,769 participants contributing comparative data. The findings indicated that eConsenting demonstrated either significantly better understanding, better understanding without statistical significance, or no significant differences in overall comprehension when compared to paper-based ICFs.

Market Players Outlook

The major companies serving the econsent in healthcare market includes Magentus Group Pty Ltd., Medable, Inc., Medrio, Inc., ObvioHealth, and Veeva Systems and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance In June 2022, uMotif partnered with ClinOne to provide a seamless experience for patients, caregivers, and sites of proven traditional, DCT, and hybrid trial solutions for eConsent, eCOA / ePRO, behavioral engagement, sensors and wearables, and more.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global econsent in healthcare market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Citadel Group Ltd.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Florence Healthcare, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Health Catalyst
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global EConsent in Healthcare Market by Entrollment Type
    • 4.1.1. On-site
    • 4.1.2. Remote Consent
  • 4.2. Global EConsent in Healthcare Market by Deployment Mode
    • 4.2.1. Cloud-Based
    • 4.2.2. Web-Based
  • 4.3. Global EConsent in Healthcare Market by Form Type
    • 4.3.1. General Consent
    • 4.3.2. General Consent With Specific Denial(S)
    • 4.3.3. General Denial With Specific Consent(S)
    • 4.3.4. General Denial

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 5thPort, LLC
  • 6.2. Calysta EMR
  • 6.3. Cloudbyz
  • 6.4. Concentric
  • 6.5. EvidentIQ Group GmbH
  • 6.6. IQVIA
  • 6.7. Magentus Group Pty Ltd.
  • 6.8. Medable, Inc.
  • 6.9. Medrio, Inc.
  • 6.10. ObvioHealth
  • 6.11. Signant Health
  • 6.12. Sitero
  • 6.13. Suvoda LLC,
  • 6.14. Thieme Compliance GmbH
  • 6.15. Veeva Systems

LIST OF TABLES

  • 1. GLOBAL ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY ENROLLMENT TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL ON-SITE ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL REMOTE ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODE, 2022-2030 ($ MILLION)
  • 5. GLOBAL ECONSENT IN HEALTHCARE CLOUD-BASED MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL ECONSENT IN HEALTHCARE WEB-BASED MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY FORM TYPE, 2022-2030 ($ MILLION)
  • 8. GLOBAL GENERAL CONSENT ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL GENERAL CONSENT WITH SPECIFIC DENIAL(S) ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL GENERAL DENIAL WITH SPECIFIC CONSENT(S) ECONSENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL GENERAL DENIAL ECONSENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY ENROLLMENT TYPE, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODE, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY FORM TYPE, 2022-2030 ($ MILLION)
  • 17. EUROPEAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. EUROPEAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY ENROLLMENT TYPE, 2022-2030 ($ MILLION)
  • 19. EUROPEAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODE, 2022-2030 ($ MILLION)
  • 20. EUROPEAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY FORM TYPE, 2022-2030 ($ MILLION)
  • 21. ASIA-PACIFIC ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY ENROLLMENT TYPE, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODE, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY FORM TYPE, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY ENROLLMENT TYPE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY FORM TYPE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ECONSENT IN HEALTHCARE MARKET SHARE BY ENROLLMENT TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL ON-SITE ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL REMOTE CONSENT ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL ECONSENT IN HEALTHCARE MARKET SHARE BY DEPLOYMENT MODE, 2022 VS 2030 (%)
  • 5. GLOBAL ECONSENT IN HEALTHCARE CLOUD-BASED MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL ECONSENT IN HEALTHCARE WEB-BASED MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL ECONSENT IN HEALTHCARE MARKET SHARE BY FORM TYPE, 2022 VS 2030 (%)
  • 8. GLOBAL GENERAL CONSENT ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL GENERAL CONSENT WITH SPECIFIC DENIAL(S) ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL GENERAL DENIAL WITH SPECIFIC CONSENT(S) ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL GENERAL DENIAL ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. US ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. CANADA ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. UK ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. FRANCE ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. GERMANY ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. ITALY ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. SPAIN ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. REST OF EUROPE ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. INDIA ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CHINA ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. JAPAN ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. SOUTH KOREA ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF ASIA-PACIFIC ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)